I have never seen this one before but it may give some insight into the neuro benefits of dhea usage.
Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity
Shi‐Fang Lu
Qianxing Mo
Shan Hu
Carrie Garippa
Neal G. Simon
First published: 06 October 2003
https://doi.org/10.1002/neu.10260
Citations: 40
PDF
TOOLS
SHARE
Abstract
The mechanism of action of dehydroepiandrosterone (DHEA), a neuroactive neurosteroid synthesized in the brains of humans and other mammals, has not been fully characterized in the adult brain. Although well known for modulatory effects on GABAA, NMDA, and σ1 receptors, studies in both CNS and peripheral target cells suggest that DHEA also may exert genomic effects via the androgen receptor (AR). The current study tested the hypothesis that DHEA was capable of producing androgenic effects in the CNS by assaying its ability to induce three characteristic effects of an androgenic compound. These included the ability to upregulate neural AR protein level in mouse brain and immortalized GT1–7 hypothalamic cells, the capacity to induce transcriptional activity through AR in CV‐1 cells transfected with an MMTV‐ARE‐CAT reporter, and competition for recombinant AR binding in a radioligand binding assay. The results showed that DHEA treatment significantly augmented AR both in vivo and in vitro, and that this effect was not blocked by trilostane (TRIL), a known 3β‐hydroxysteroid dehydrogenase (3β‐HSD) inhibitor. DHEA also promoted AR‐mediated CAT reporter expression and competed with dihydrotestosterone (DHT) for binding to recombinant AR in a cell‐free system. These data indicate that DHEA possesses intrinsic androgenic activity that is potentially independent of metabolic conversion to other androgens, and that it can affect gene function through the AR. In combination with its modulation of neurotransmitter receptors at the cell membrane level, the findings suggest that the mechanism of action of DHEA in the brain can involve a “crosstalk” cellular signaling system that involves both nongenomic and genomic components. © 2003 Wiley Periodicals, Inc. J Neurobiol 57: 163–171, 2003
I figured this forum was an appropriate place as Iconic, to my knowledge, is the only company currently marketing a DHEA with this purpose in mind.
Error - Cookies Turned Off
onlinelibrary.wiley.com
Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity
Shi‐Fang Lu
Qianxing Mo
Shan Hu
Carrie Garippa
Neal G. Simon
First published: 06 October 2003
https://doi.org/10.1002/neu.10260
Citations: 40
TOOLS
SHARE
Abstract
The mechanism of action of dehydroepiandrosterone (DHEA), a neuroactive neurosteroid synthesized in the brains of humans and other mammals, has not been fully characterized in the adult brain. Although well known for modulatory effects on GABAA, NMDA, and σ1 receptors, studies in both CNS and peripheral target cells suggest that DHEA also may exert genomic effects via the androgen receptor (AR). The current study tested the hypothesis that DHEA was capable of producing androgenic effects in the CNS by assaying its ability to induce three characteristic effects of an androgenic compound. These included the ability to upregulate neural AR protein level in mouse brain and immortalized GT1–7 hypothalamic cells, the capacity to induce transcriptional activity through AR in CV‐1 cells transfected with an MMTV‐ARE‐CAT reporter, and competition for recombinant AR binding in a radioligand binding assay. The results showed that DHEA treatment significantly augmented AR both in vivo and in vitro, and that this effect was not blocked by trilostane (TRIL), a known 3β‐hydroxysteroid dehydrogenase (3β‐HSD) inhibitor. DHEA also promoted AR‐mediated CAT reporter expression and competed with dihydrotestosterone (DHT) for binding to recombinant AR in a cell‐free system. These data indicate that DHEA possesses intrinsic androgenic activity that is potentially independent of metabolic conversion to other androgens, and that it can affect gene function through the AR. In combination with its modulation of neurotransmitter receptors at the cell membrane level, the findings suggest that the mechanism of action of DHEA in the brain can involve a “crosstalk” cellular signaling system that involves both nongenomic and genomic components. © 2003 Wiley Periodicals, Inc. J Neurobiol 57: 163–171, 2003
I figured this forum was an appropriate place as Iconic, to my knowledge, is the only company currently marketing a DHEA with this purpose in mind.